Gliapharm is a biotech startup based in Geneva, Switzerland, dedicated to reimagining brain health by focusing on the role of glial cells in brain function and health. Their team of experts is leveraging decades of research to develop new drugs targeting glia-mediated pathways for neuroprotection and cognitive function maintenance in patients with challenging neurological and psychiatric disorders. By stimulating energy utilization in the brain through astrocytes, Gliapharm aims to address brain hypometabolism, a core feature of various neurological conditions.
Mahsa Shoaran, Uisub Shin, Mohammad Ali Shaeri
Maria del Carmen Sandi Perez, Dogukan Hazar Ülgen, Thamyris Silva
Henning Paul-Julius Stahlberg, Amanda Jennifer Lewis, Marta Di Fabrizio, Domenic Burger, Carolin Böing